Colorectal cancer vaccines: The current scenario and future prospects

被引：24

作者：

Jia, Wenqing ^{[1
,2
]}

Zhang, Tao ^{[1
,2
]}

Huang, Haiyan ^{[1
,2
]}

Feng, Haoran ^{[1
,2
]}

Wang, Shaodong ^{[1
,2
]}

Guo, Zichao ^{[1
,2
]}

Luo, Zhiping ^{[1
,2
]}

Ji, Xiaopin ^{[1
,2
]}

Cheng, Xi ^{[1
,2
]}

Zhao, Ren ^{[1
,2
]}

机构：

[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Gen Surg, Sch Med, Shanghai, Peoples R China

[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Digest Surg, Sch Med, Shanghai, Peoples R China

来源：

FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷

基金：

中国国家自然科学基金;

关键词：

colorectal cancer; vaccine; neoantigen; nanovaccines; immunotherapy; ACTIVE SPECIFIC IMMUNOTHERAPY; REDUCE TUMOR-GROWTH; I CLINICAL-TRIAL; PHASE-I; GM-CSF; NEUTRALIZING ANTIBODIES; ANTITUMOR EFFICACY; IMMUNE-RESPONSES; COLON-CANCER; ANTIGEN; 5T4;

D O I：

10.3389/fimmu.2022.942235

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Colorectal cancer (CRC) is one of the most common cancers worldwide. Current therapies such as surgery, chemotherapy, and radiotherapy encounter obstacles in preventing metastasis of CRC even when applied in combination. Immune checkpoint inhibitors depict limited effects due to the limited cases of CRC patients with high microsatellite instability (MSI-H). Cancer vaccines are designed to trigger the elevation of tumor-infiltrated lymphocytes, resulting in the intense response of the immune system to tumor antigens. This review briefly summarizes different categories of CRC vaccines, demonstrates the current outcomes of relevant clinical trials, and provides particular focus on recent advances on nanovaccines and neoantigen vaccines, representing the trend and emphasis of CRC vaccine development.

引用

页数：13

共 110 条

[1] A phase II study of active specific immunotherapy and 5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma [J].

Baars, A ;

Claessen, AME ;

Wagstaff', J ;

Giaccone, G ;

Scheper, RJ ;

Meijer, S ;

Schakel, MJAG ;

Gall, HE ;

Meijer, CJLM ;

Vermorken, JB ;

Pinedo, HM ;

van den Eertwegh, AJM .

BRITISH JOURNAL OF CANCER, 2002, 86 (08) :1230-1234

[2] The Landscape of Tumor-Specific Antigens in Colorectal Cancer [J].

Bakarurraini, Nurul Ainaa Adilah Rus ;

Ab Mutalib, Nurul Syakima ;

Jamal, Rahman ;

Abu, Nadiah .

VACCINES, 2020, 8 (03) :1-17

[3] The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution [J].

Ballhausen, Alexej ;

Przybilla, Moritz Jakob ;

Jendrusch, Michael ;

Haupt, Saskia ;

Pfaffendorf, Elisabeth ;

Seidler, Florian ;

Witt, Johannes ;

Hernandez Sanchez, Alejandro ;

Urban, Katharina ;

Draxlbauer, Markus ;

Krausert, Sonja ;

Ahadova, Aysel ;

Kalteis, Martin Simon ;

Pfuderer, Pauline L. ;

Heid, Daniel ;

Stichel, Damian ;

Gebert, Johannes ;

Bonsack, Maria ;

Schott, Sarah ;

Blaeker, Hendrik ;

Seppala, Toni ;

Mecklin, Jukka-Pekka ;

Ten Broeke, Sanne ;

Nielsen, Maartje ;

Heuveline, Vincent ;

Krzykalla, Julia ;

Benner, Axel ;

Riemer, Angelika Beate ;

von Knebel Doeberitz, Magnus ;

Kloor, Matthias .

NATURE COMMUNICATIONS, 2020, 11 (01)

[4] Peptide Vaccine Therapy in Colorectal Cancer [J].

Bartnik, Aleksandra ;

Nirmal, Ajit Johnson ;

Yang, Shi-Yu .

VACCINES, 2013, 1 (01) :1-16

[5] Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions [J].

Berry, John ;

Vreeland, Timothy ;

Trappey, Alfred ;

Hale, Diane ;

Peace, Kaitlin ;

Tyler, Joshua ;

Walker, Avery ;

Brown, Ramon ;

Herbert, Garth ;

Yi, Fia ;

Jackson, Doreen ;

Clifton, Guy ;

Peoples, George E. .

EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (03) :235-245

[6] A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint [J].

Bever, Katherine M. ;

Thomas, Dwayne L., II ;

Zhang, Jiajia ;

Rivera, Ernie A. Diaz ;

Rosner, Gary L. ;

Zhu, Qingfeng ;

Nauroth, Julie M. ;

Christmas, Brian ;

Thompson, Elizabeth D. ;

Anders, Robert A. ;

Judkins, Carol ;

Liu, Meizheng ;

Jaffee, Elizabeth M. ;

Ahuja, Nita ;

Zheng, Lei ;

Azad, Nilofer S. .

CLINICAL EPIGENETICS, 2021, 13 (01)

[7] Advancements in prophylactic and therapeutic nanovaccines [J].

Bhardwaj, Prateek ;

Bhatia, Eshant ;

Sharma, Shivam ;

Ahamad, Nadim ;

Banerjee, Rinti .

ACTA BIOMATERIALIA, 2020, 108 :1-21

[8] Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma [J].

Bilusic, Marijo ;

Heery, Christopher R. ;

Arlen, Philip M. ;

Rauckhorst, Myrna ;

Apelian, David ;

Tsang, Kwong Y. ;

Tucker, Jo A. ;

Jochems, Caroline ;

Schlom, Jeffrey ;

Gulley, James L. ;

Madan, Ravi A. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (03) :225-234

[9] Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification [J].

Bulik-Sullivan, Brendan ;

Busby, Jennifer ;

Palmer, Christine D. ;

Davis, Matthew J. ;

Murphy, Tyler ;

Clark, Andrew ;

Busby, Michele ;

Duke, Fujiko ;

Yang, Aaron ;

Young, Lauren ;

Ojo, Noelle C. ;

Caldwell, Kamilah ;

Abhyankar, Jesse ;

Boucher, Thomas ;

Hart, Meghan G. ;

Makarov, Vladimir ;

De Montpreville, Vincent Thomas ;

Mercier, Olaf ;

Chan, Timothy A. ;

Scagliotti, Giorgio ;

Bironzo, Paolo ;

Novello, Silvia ;

Karachaliou, Niki ;

Rosell, Rafael ;

Anderson, Ian ;

Gabrail, Nashat ;

Hrom, John ;

Limvarapuss, Chainarong ;

Choquette, Karin ;

Spira, Alexander ;

Rousseau, Raphael ;

Voong, Cynthia ;

Rizvi, Naiyer A. ;

Fadel, Elie ;

Frattini, Mark ;

Jooss, Karin ;

Skoberne, Mojca ;

Francis, Joshua ;

Yelensky, Roman .

NATURE BIOTECHNOLOGY, 2019, 37 (01) :55-+

[10] Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers [J].

Carlsen, Lindsey ;

Huntington, Kelsey E. ;

El-Deiry, Wafik S. .

CANCERS, 2022, 14 (04)

← 1 2 3 4 5 6 7 8 9 10 →